These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

827 related items for PubMed ID: 23973949

  • 1. Nonischemic cardiomyopathy substrate and ventricular tachycardia in the setting of coronary artery disease.
    Aldhoon B, Tzou WS, Riley MP, Lin D, Callans DJ, Hutchinson MD, Dixit S, Garcia FC, Zado ES, Marchlinski FE.
    Heart Rhythm; 2013 Nov; 10(11):1622-7. PubMed ID: 23973949
    [Abstract] [Full Text] [Related]

  • 2. Refractory ventricular tachycardia secondary to cardiac sarcoid: electrophysiologic characteristics, mapping, and ablation.
    Koplan BA, Soejima K, Baughman K, Epstein LM, Stevenson WG.
    Heart Rhythm; 2006 Aug; 3(8):924-9. PubMed ID: 16876741
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. High-density substrate-guided ventricular tachycardia ablation: role of activation mapping in an attempt to improve procedural effectiveness.
    Carbucicchio C, Ahmad Raja N, Di Biase L, Volpe V, Dello Russo A, Trivedi C, Bartoletti S, Zucchetti M, Casella M, Russo E, Santangeli P, Moltrasio M, Tundo F, Fassini G, Natale A, Tondo C.
    Heart Rhythm; 2013 Dec; 10(12):1850-8. PubMed ID: 24055940
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Arrhythmogenic substrate at the interventricular septum as a target site for radiofrequency catheter ablation of recurrent ventricular tachycardia in left dominant arrhythmogenic cardiomyopathy.
    Havranek S, Palecek T, Kovarnik T, Vitkova I, Psenicka M, Linhart A, Wichterle D.
    BMC Cardiovasc Disord; 2015 Mar 10; 15():18. PubMed ID: 25887693
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Importance of Ventricular Tachycardia Induction and Mapping for Patients Referred for Epicardial Ablation.
    Nazer B, Woods C, Dewland T, Moyers B, Badhwar N, Gerstenfeld EP.
    Pacing Clin Electrophysiol; 2015 Nov 10; 38(11):1333-42. PubMed ID: 26228002
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 42.